Stock Options (Details Textual) (USD $)
|
12 Months Ended | 1 Months Ended | 1 Months Ended | 12 Months Ended | 12 Months Ended | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2012
|
Dec. 31, 2011
|
Dec. 31, 2010
|
Sep. 30, 2011
Maximum [Member]
|
Sep. 30, 2011
Minimum [Member]
|
Sep. 27, 2011
Directors [Member]
|
Sep. 27, 2011
Employees [Member]
|
Sep. 30, 2011
AxoGen Plan [Member]
|
Dec. 31, 2012
AxoGen Plan [Member]
|
Dec. 31, 2011
AxoGen Plan [Member]
|
Sep. 27, 2011
AxoGen Plan [Member]
|
Dec. 31, 2012
AxoGen Plan [Member]
Maximum [Member]
|
Dec. 31, 2012
AxoGen Plan [Member]
Minimum [Member]
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||||||
Issuance of shares | 18,144,658 | 2,750,000 | |||||||||||
Merger options to purchase shares were available for issuance | 1,799,991 | 1,945,688 | 447,659 | ||||||||||
Issuance of shares under AxoGen Plan | 2,300,000 | ||||||||||||
Shares vested percentage | 25.00% | 12.50% | |||||||||||
Vested period, Description | every six months over a four-year period | ||||||||||||
Options issued to consultants vest over the service period | 10 years | 3 years | |||||||||||
Options term range | P10Y | P7Y | |||||||||||
Weighted average period | 3 years 15 days | 0 years | |||||||||||
Average fair value of options granted | $ 2.99 | $ 0.42 | |||||||||||
Intrinsic value of options exercised | $ 173,000 | $ 190,000 | |||||||||||
Intrinsic value of options outstanding | 1,126,000 | 288,000 | |||||||||||
Intrinsic value of options exercisable | 391,000 | 0 | |||||||||||
Common stock ratio | 0.03727336 | 0.03727336 | |||||||||||
Incremental cost | 19,769 | 38,521 | |||||||||||
Total future stock compensation expense related to nonvested awards | 1,405,000 | 1,405,150 | |||||||||||
Stock Options (Textual) [Abstract] | |||||||||||||
Vesting Period | 1 year | ||||||||||||
Stock-based compensation expense | $ 495,077 | $ 250,044 | |||||||||||
Stock options granted | 267,576 | 1,141,952 |